Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Reactive oxygen species contribute to oridonin-induced apoptosis and autophagy in human cervical carcinoma HeLa cells.
Zhang YH, Wu YL, Tashiro S, Onodera S, Ikejima T.
Acta Pharmacol Sin. 2011 Oct;32(10):1266-75. doi: 10.1038/aps.2011.92. Epub 2011 Sep 5.
Related citations
Genotyping of human papillomavirus in triaging of low-grade cervical cytology.
Söderlund-Strand A, Eklund C, Kemetli L, Grillner L, Törnberg S, Dillner J, Dillner L.
Am J Obstet Gynecol. 2011 Aug;205(2):145.e1-6. Epub 2011 Apr 7.
Fertility preserving options in patients with gynecologic malignancies.
Eskander RN, Randall LM, Berman ML, Tewari KS, Disaia PJ, Bristow RE.
Am J Obstet Gynecol. 2011 Aug;205(2):103-10. Epub 2011 Mar 16. Review.
Characterization of gut-derived intraepithelial lymphocyte (IEL) residing in human papillomavirus (HPV)-infected intraepithelial neoplastic lesions.
Kojima S, Kawana K, Fujii T, Yokoyama T, Miura S, Tomio K, Tomio A, Yamashita A, Adachi K, Sato H, Nagamatsu T, Schust DJ, Kozuma S, Taketani Y.
Am J Reprod Immunol. 2011 Nov;66(5):435-43. doi: 10.1111/j.1600-0897.2011.01041.x. Epub 2011 Jul 12.
JWA enhances As₂O₃-induced tubulin polymerization and apoptosis via p38 in HeLa and MCF-7 cells.
Shen L, Xu W, Li A, Ye J, Zhou J.
Apoptosis. 2011 Nov;16(11):1177-93.
HPV-16 and HLA-DRB1 alleles are associated with cervical carcinoma in Mexican Mestizo women.
Alaez-Verson C, Berumen-Campos J, Munguía-Saldaña A, Flores-Aguilar H, Guardado-Estrada M, Rodríguez-Gomez A, Gorodezky-Lauferman C.
Arch Med Res. 2011 Jul;42(5):421-5. doi: 10.1016/j.arcmed.2011.07.002.
Adjunctive testing for cervical cancer screening in low resource settings.
Bhatla N, Puri K, Kriplani A, Iyer VK, Mathur SR, Mani K, Pandey RM.
Aust N Z J Obstet Gynaecol. 2012 Apr;52(2):133-9. doi: 10.1111/j.1479-828X.2011.01402.x. Epub 2012 Jan 25.
Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence.
Hernandez-Flores G, Ortiz-Lazareno PC, Lerma-Diaz JM, Dominguez-Rodriguez JR, Jave-Suarez LF, Aguilar-Lemarroy Adel C, de Celis-Carrillo R, del Toro-Arreola S, Castellanos-Esparza YC, Bravo-Cuellar A.
BMC Cancer. 2011 Nov 10;11:483.
Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results.
Elit L, Krzyzanowska M, Saskin R, Barbera L, Razzaq A, Lofters A, Yeritsyan N, Bierman A.
Can Fam Physician. 2012 Jan;58(1):e22-31.
Knowledge, attitude and practices regarding cervical cancer and screening among women visiting primary health care in Qatar.
Al-Meer FM, Aseel MT, Al-Khalaf J, Al-Kuwari MG, Ismail MF.
East Mediterr Health J. 2011 Nov;17(11):855-61.
Perceptions of HPV and cervical cancer among Haitian immigrant women: implications for vaccine acceptability.
Kobetz E, Menard J, Hazan G, Koru-Sengul T, Joseph T, Nissan J, Barton B, Blanco J, Kornfeld J.
Educ Health (Abingdon). 2011 Dec;24(3):479. Epub 2011 Dec 7.
[Left renal vessels as an upper margin of para-aortic lymphadenectomy in cervical cancer: because we could or because we should?].
Ouldamer L, Marret H, Body G.
Gynecol Obstet Fertil. 2012 Feb;40(2):69-70. Epub 2012 Jan 21. French. No abstract available.
Loop electrosurgical excision procedures in Israel.
Siegler E, Bornstein J; Israeli Colposcopy Network.
Gynecol Obstet Invest. 2011;72(2):85-9. Epub 2011 Aug 9.
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery.
Ferrandina G, Carbone A, Macchia G, Petrillo M, Lucidi A, Morganti AG.
Gynecol Obstet Invest. 2011;72(2):141-4. Epub 2011 Jul 27.
Prognostic significance of adenocarcinoma histology in women with cervical cancer.
Galic V, Herzog TJ, Lewin SN, Neugut AI, Burke WM, Lu YS, Hershman DL, Wright JD.
Gynecol Oncol. 2012 May;125(2):287-91. Epub 2012 Jan 18.
Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening.
Rijkaart DC, Berkhof J, van Kemenade FJ, Coupe VM, Hesselink AT, Rozendaal L, Heideman DA, Verheijen RH, Bulk S, Verweij WM, Snijders PJ, Meijer CJ.
Int J Cancer. 2012 Feb 1;130(3):602-10. doi: 10.1002/ijc.26056. Epub 2011 May 5.
Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
Gong L, Lou JY, Wang P, Zhang JW, Liu H, Peng ZL.
Int J Gynaecol Obstet. 2012 Apr;117(1):23-6. Epub 2012 Jan 21.
Biopsy-diagnosed female genital schistosomiasis in rural Limpopo, South Africa.
van Bogaert LJ.
Int J Gynaecol Obstet. 2011 Oct;115(1):75-6. Epub 2011 Jul 20. No abstract available.
A prospective randomized controlled study on multiple neoadjuvant treatments for patients with stage IB2 to IIA cervical cancer.
Wen H, Wu X, Li Z, Wang H, Zang R, Sun M, Huang X, Zhang Z, Cai S.
Int J Gynecol Cancer. 2012 Feb;22(2):296-302.
Preoperative differential diagnosis of minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia of the uterine cervix: a multicenter study of clinicopathology and magnetic resonance imaging findings.
Takatsu A, Shiozawa T, Miyamoto T, Kurosawa K, Kashima H, Yamada T, Kaku T, Mikami Y, Kiyokawa T, Tsuda H, Ishii K, Togashi K, Koyama T, Fujinaga Y, Kadoya M, Hashi A, Susumu N, Konishi I.
Int J Gynecol Cancer. 2011 Oct;21(7):1287-96.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on